Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Free Cash Flow (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Free Cash Flow for 6 consecutive years, with -$2.5 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 77.77% to -$2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$31.1 million through Dec 2025, up 31.73% year-over-year, with the annual reading at -$31.1 million for FY2025, 31.73% up from the prior year.
  • Free Cash Flow hit -$2.5 million in Q4 2025 for Rapid Micro Biosystems, up from -$9.7 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$2.5 million in Q4 2025 to a low of -$19.4 million in Q3 2021.
  • Historically, Free Cash Flow has averaged -$12.3 million across 5 years, with a median of -$11.4 million in 2021.
  • Biggest five-year swings in Free Cash Flow: crashed 187.95% in 2021 and later skyrocketed 77.77% in 2025.
  • Year by year, Free Cash Flow stood at -$15.2 million in 2021, then increased by 18.24% to -$12.5 million in 2022, then rose by 21.9% to -$9.7 million in 2023, then decreased by 15.51% to -$11.2 million in 2024, then surged by 77.77% to -$2.5 million in 2025.
  • Business Quant data shows Free Cash Flow for RPID at -$2.5 million in Q4 2025, -$9.7 million in Q3 2025, and -$9.7 million in Q2 2025.